id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0103-0016,FDA,FDA-2011-N-0103,Reference 6 - Phage Isolated From Lysogenic Bacillus Anthracis,Supporting & Related Material,Background Material,2016-01-12T05:00:00Z,2016,1,,,2016-01-12T18:39:37Z,,0,0,0900006481e03459
FDA-2011-N-0103-0017,FDA,FDA-2011-N-0103,Reference 7 - A Colour Atlas of Bacillus Species,Supporting & Related Material,Background Material,2016-01-12T05:00:00Z,2016,1,,,2016-01-12T18:39:45Z,,0,0,0900006481e0345a
FDA-2011-N-0103-0018,FDA,FDA-2011-N-0103,Reference 8 - Draft Guideline for Industry and FDA Staff Class II Special Controls Guidline: In Vitro Diagnostic Devices for Bacillus spp. Detection,Supporting & Related Material,Background Material,2016-01-12T05:00:00Z,2016,1,,,2016-01-12T18:39:51Z,,0,0,0900006481e0345e
FDA-2011-N-0103-0015,FDA,FDA-2011-N-0103,Reference 5 - Differential Diagnosis of Bacillus Cereus Bacillus Anthracis and Bacillus Cereus Var. Mycoides,Supporting & Related Material,Background Material,2016-01-12T05:00:00Z,2016,1,,,2016-01-12T18:39:33Z,,0,0,0900006481e032e5
FDA-2011-N-0103-0012,FDA,FDA-2011-N-0103,Reference 2 - Validation of the use of Gamma Phage for Identifying Bacillus Anthracis,Supporting & Related Material,Background Material,2016-01-12T05:00:00Z,2016,1,,,2016-01-12T18:39:19Z,,0,0,0900006481e032b1
FDA-2011-N-0103-0014,FDA,FDA-2011-N-0103,Reference 4 - Specific Identification of Bacillus Anthracis by Means of a Variant Bacteriophage,Supporting & Related Material,Background Material,2016-01-12T05:00:00Z,2016,1,,,2016-01-12T18:39:29Z,,0,0,0900006481e032e4
FDA-2011-N-0103-0011,FDA,FDA-2011-N-0103,Reference 1 -  Transcript of Microbiology Devices Panel meeting March 7 2002,Supporting & Related Material,Background Material,2016-01-12T05:00:00Z,2016,1,,,2016-01-12T18:39:15Z,,0,0,0900006481e02ead
FDA-2011-N-0103-0010,FDA,FDA-2011-N-0103,List of References,Supporting & Related Material,List,2016-01-12T05:00:00Z,2016,1,,,2016-01-12T18:39:10Z,,0,0,0900006481e031a7
FDA-2011-N-0103-0013,FDA,FDA-2011-N-0103,Reference 3 - Production and Validation of the Use of Gamma Phage for the Identification of Bacillus Anthracis,Supporting & Related Material,Background Material,2016-01-12T05:00:00Z,2016,1,,,2016-01-12T18:39:25Z,,0,0,0900006481e032b2
FDA-2011-N-0103-0019,FDA,FDA-2011-N-0103,"Reference 9 - Microbiology Devices; Classification of In Vitro Diagnostic Device for Bacillus Species Detection - Preliminary Regulatory Impact Analysis, Initial Regulatory Flexibility Analysis, and Unfunded Mandates Reform Act Analysis",Supporting & Related Material,Background Material,2016-01-12T05:00:00Z,2016,1,,,2016-01-12T18:39:55Z,,0,0,0900006481e0345f
FDA-2011-N-0103-0020,FDA,FDA-2011-N-0103,Reference 10 - Laboratory Response Network LRN Level A laboratory procedures for identification of Bacillus Anthracis,Supporting & Related Material,Background Material,2016-01-12T05:00:00Z,2016,1,,,2016-01-12T18:40:02Z,,0,0,0900006481e034a8